Jane E. Aubin BSc, PhD

Dr. Jane E. Aubin was appointed Chief Scientific Officer (CSO) and Vice-President (VP), Research at CIHR in July 2011, later renamed Research and Knowledge Translation Portfolio. As CSO, Dr. Aubin is responsible for the oversight of all scientific affairs at CIHR and provides CIHR with expert advice on matters relevant to science and technology, potential opportunities and emerging orientations and trends in the national and international health research community. As VP, Research and Knowledge Translation, she is responsible for all aspects of adjudication of grants and awards at CIHR and finally, as a member of the Scientific Council, she participates in the development, implementation, and reporting on CIHR's research and knowledge translation strategy.

Dr. Aubin’s career path has included several senior academic administrative positions, including Chair of the Graduate Department of Dentistry and Director of Postgraduate Dental Education and Chair of the Department of Anatomy and Cell Biology at the University of Toronto. She is currently a member of the Faculty of Medicine at the University of Toronto where she is a Professor of Molecular Genetics. Dr. Aubin has been Scientific Director and CEO of the Canadian Arthritis Network of Centres of Excellence and until recently, Scientific Director of CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA), specializing in arthritis, musculoskeletal, oral and skin conditions. 

Dr. Aubin received a B.Sc. (Hons; Chemistry and Mathematics) and the Gold Medal in Chemistry at Queen's University in Kingston. She then completed her Ph.D. in Medical Biophysics at the University of Toronto. She later did her postdoctoral training in Molecular Biology and Biochemistry at the Max Planck Institute for Biophysical Chemistry in Goettingen, Germany.